1. Market Research
  2. > Pathology Industry

anemia Industry, May 2016 Market Reports from Top Publishers

You might be interested in: Molecular Diagnostic, In Vitro Diagnostic Reagent, Biosimilar, Clinical Trial, Pharmaceutical, Erythropoietin, Injectable Delivery, Injectable Drug Delivery, Therapeutics.


 
1-10 of 65 reports for Anemia

Purchase Reports From Reputable Market Research Publishers

Global Anemia Partnering 2010 to 2016

Global Anemia Partnering 2010 to 2016

  • $ 1 495
  • Industry report
  • May 2016
  • by Currentpartnering

The Global Therapy Partnering Terms and Agreements since 2010 report provides understanding and access to partnering deals and agreements entered into by the world’s leading healthcare companies. • ...

Chemotherapy Induced Anemia - Pipeline Review, H1 2016

Chemotherapy Induced Anemia - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • March 2016
  • by Global Markets Direct

Chemotherapy Induced Anemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Chemotherapy Induced Anemia - Pipeline Review, H1 2016’, provides an overview of the Chemotherapy Induced ...

Iron Deficiency Anemia - Pipeline Review, H1 2016

Iron Deficiency Anemia - Pipeline Review, H1 2016

  • $ 2 000
  • Company report
  • February 2016
  • by Global Markets Direct

Iron Deficiency Anemia - Pipeline Review, H1 2016 Summary Global Markets Direct’s, ‘Iron Deficiency Anemia - Pipeline Review, H1 2016’, provides an overview of the Iron Deficiency Anemia pipeline ...

 Iron Deficiency Anemia-Pipeline Insights, 2016

Iron Deficiency Anemia-Pipeline Insights, 2016

  • $ 1 250
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s, “ Iron Deficiency Anemia-Pipeline Insights, 2016”, report provides in depth insights on the pipeline drugs and their development activities around the Iron Deficiency Anemia. ...

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Refractory Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Acquired (Autoimmune) Hemolytic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed ...

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Iron Deficiency Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, ...

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Aplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Congenital Hypoplastic Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug ...

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

  • $ 2 000
  • Industry report
  • January 2016
  • by Delve Insight

SUMMARY DelveInsight’s Report, “Pernicious Anemia-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase ...

About 3 300 reports for Anemia

Download Unlimited Documents from Trusted Public Sources

Fibrogen - Annual Report, October 2014

  • October 2014
    284 pages
  • Blood Disease  

    Pharmaceutical  

  • China  

    United States  

View report >

Pathology Description

January 2014

Pathology Description

January 2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.